News

Array BioPharma To Present At The Cowen 38th Annual Healthcare Conference

BOULDER, Colo., March 5, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Cowen 38th Annual Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Cowen 38th Annual Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer, Array BioPharma

Date:

Monday, March 12, 2018

Time:

11:20 a.m. Eastern Time

Webcast:

http://wsw.com/webcast/cowen46/arry/

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate Communications
(303) 381-6600
ir@arraybiopharma.com

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-cowen-38th-annual-healthcare-conference-300608207.html

SOURCE Array BioPharma Inc.

ShareThis Copy and Paste